{
  "id": 9698549,
  "title": "Japan approval, a 27% surge: the diagnostics stock our models picked in September",
  "url": "https://urgent.news/2026/09/25/japan-approval-a-27-surge-the-diagnostics-stock-our-models-picked-in",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-25T04:22:14.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/stock-market-news/japan-approval-a-27-surge-the-diagnostics-stock-our-models-picked-in-september-4916588"
  },
  "original_language": "en",
  "account": "Natera, a diagnostics stock, has surged by 27% since the beginning of September, reaching new all-time highs. Investing.com's ProPicks AI-powered Strategies added Natera to its portfolio on September 1, capitalizing on three distinct catalysts that drove the increase. On September 18, Natera unveiled the largest-ever minimal-residual-disease study in lung cancer, showing that Signatera-negative patients had a 25-percentage-point higher three-year recurrence-free survival rate compared to positive patients. Later on September 22, Japan's PMDA approved Signatera as a companion diagnostic for muscle-invasive bladder cancer, with a commercial launch scheduled for the first half of 2027. The stock's consensus price target stands at $330.83, with 23 analysts rating the stock as a strong buy or buy. Natera's performance has outperformed the S&P 500 Health Care index by 2.37 percentage points in September.",
  "summary": null,
  "key_points": [
    "Natera's stock surged 27% since September 1",
    "PMDA approved Signatera for muscle-invasive bladder cancer",
    "Consensus price target at $330.83, 23 buy/sell ratings"
  ],
  "editors_take": "Japan's approval of Signatera as a companion diagnostic for muscle-invasive bladder cancer boosts Natera's prospects, aligning with a surge in stock value and analyst consensus on its growth potential.",
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "CNBC World",
        "title": "Oracle Japan shares surge 7% after record fiscal first quarter, bucking selloff of U.S. parent",
        "url": "https://urgent.news/2026/09/25/oracle-japan-shares-surge-7-after-record-fiscal-first-quarter-bucking",
        "published": "2026-09-25T01:56:24.000Z"
      },
      {
        "outlet": "Investing.com",
        "title": "Why is Oracle Japan stock surging today?",
        "url": "https://urgent.news/2026/09/25/why-is-oracle-japan-stock-surging-today",
        "published": "2026-09-25T03:33:41.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}